With Mareana, you can connect patient, process, and manufacturing data to identify the root causes of slow growth, improve CAR-T yields, and enhance manufacturing consistency.
The primary causes of slow growth in CAR-T manufacturing
The impact of activation, modification, and culture conditions on yield
Why genealogy and contextualized manufacturing data are critical for root cause analysis
Strategies for improving consistency, scalability, and manufacturing performance in CAR-T production

Good Manufacturing
Practice

Good Manufacturing
Practice
/ ANY QUESTIONS? WE'D LOVE TO HELP
Slow growth in CAR-T manufacturing occurs when T cells fail to proliferate efficiently during the expansion phase, resulting in lower cell yields and production delays. Common causes include patient-specific factors, inefficient cell activation and genetic modification processes, suboptimal culture conditions, and cell senescence. Identifying these root causes is critical for improving manufacturing consistency and ensuring timely delivery of CAR-T therapies.
Manufacturers can identify the root cause of slow growth by leveraging integrated manufacturing data, advanced analytics, and machine learning. A data-driven approach enables teams to analyze patient data, process conditions, cell modification parameters, and culture environments to uncover hidden patterns and correlations that impact cell proliferation. This allows for targeted interventions that improve production outcomes and reduce batch failures.
Culture conditions play a critical role in CAR-T cell growth and expansion. Factors such as media composition, oxygen levels, nutrient availability, temperature, and pH directly influence cell proliferation and viability. Even small variations in these parameters can reduce cell yields and impact manufacturing success. Real-time monitoring and optimization of culture conditions help maintain consistent growth and improve product quality.
Machine learning improves CAR-T manufacturing by analyzing large volumes of process data to identify patterns, predict growth outcomes, and detect anomalies before they become critical issues. Predictive models can forecast the likelihood of slow growth, allowing manufacturers to proactively adjust process parameters and prevent batch failures. This leads to higher yields, better consistency, and more efficient manufacturing operations.
A data-driven approach helps CAR-T manufacturers improve patient outcomes, increase cell yields, reduce batch variability, and lower production costs. By identifying the factors contributing to slow growth, manufacturers can optimize processes, minimize rework, improve regulatory compliance, and ensure more reliable delivery of therapies. Enhanced traceability and predictive analytics also support continuous process improvement.
Mareana provides a comprehensive platform for integrating manufacturing, patient, and process data into a single genealogy. Using advanced analytics, machine learning, and root cause analysis capabilities, the platform helps manufacturers identify the factors driving slow growth, predict potential issues, and optimize production conditions. This enables proactive decision-making, reduces batch failures, and improves overall manufacturing efficiency and consistency.